The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease

Published:2020-02 Issue: Volume:152 Page:104617
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Raj Desh,Tomar Bhawna,Lahiri Amit,Mulay Shrikant R.

Funder

Department of Biotechnology, Government of India

Science and Engineering Board (SERB), Government of India

Publisher

Elsevier BV

Subject

Pharmacology

Reference123 articles.

1. The gut microbiota of rural papua new guineans: composition, diversity patterns, and ecological processes;Martinez;Cell Rep.,2015

2. Gut microbiome in chronic kidney disease;Armani;Curr. Hypertens. Rep.,2017

3. The intestinal microbiota and cardiovascular disease;Katsimichas;Cardiovasc. Res.,2019

4. The heart and the gut;Rogler;Eur. Heart J.,2014

5. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice;Le Roy;Gut,2013

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of MAFLD defined by fatty liver index or ultrasonography on kidney function decline in the general population;Scientific Reports;2024-09-11

2. Joint effects of sleep disturbance and renal function impairment on incident new‐onset severe metabolic dysfunction‐associated steatotic liver disease;Diabetes, Obesity and Metabolism;2024-08-08

3. Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period;Hepatology Research;2024-08-07

4. The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)—A Narrative Review;International Journal of Molecular Sciences;2024-06-27

5. Novel applications of Yinhua Miyanling tablets in ulcerative colitis treatment based on metabolomics and network pharmacology;Phytomedicine;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3